A detailed history of Mb, Levis & Associates, LLC transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 90 shares of TLRY stock, worth $39. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 90 -0.0%
Holding current value
$39
Previous $120,000 50.83%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 07, 2025

BUY
$2.58 - $4.68 $232 - $421
90 New
90 $242,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $269M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Mb, Levis & Associates, LLC Portfolio

Follow Mb, Levis & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mb, Levis & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mb, Levis & Associates, LLC with notifications on news.